chrisvoncsefalvay/vaers-outcomes huggingface dataset:
09/18/2021 abdominal issues Pain around the belly button then next day belly pain back pain and nausea. 04:00 AM 09/20/201 ER - hospital CAT scan , and lab work. Liter of 1 liter of Fluids and 8 hours of observation cracker and juice to see if he could maintain on his stomach and sent home   Was diagnosis with Mild Pancreatitis no history no gallstone, alcohol and he did not fit the profile.
Patient returned to pharmacy on 09/27/2010 showed a dark blue bruise at injection site about 35 mm diameter. Said she went to ER Saturday and was given antibiotics and said she was told she had "cellulitis." She appeared unharmed and said arm was sore but reported no other symptoms. (Husband received shot at same time without incident).
This Non valid spontaneous report was received from a registered nurse and refers to an unspecified number of unspecified patients of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On dates on or after 21-SEP-2017, the patients were vaccinated with improperly stored dose of PEDVAXHIB for prophylaxis, lot# N000238 with expiration date of 25-OCT-2019, lot# N003701 with expiration date of 01-NOV-2019, lot# N008079 with expiration date of 02-DEC-2019, lot# N012920 with expiration date of 07-FEB-2020 (strength, dose, route and frequency were not reported); or with improperly stored dose of RECOMBIVAX HB for prophylaxis, lot# N020613 with expiration date of 05-MAY-2020, lot# N002202 with expiration date of 04-NOV-2019, lot# N011851 with expiration date of 19-DEC-2019; or with improperly stored dose of ROTATEQ)orally, for prophylaxis, lot# N000175 with expiration date of 20-SEP-2018, lot# N005618 with expiration date of 04-OCT-2018, lot# N005078 with expiration date of 22-NOV-2018; or with improperly stored dose of VAQTA for prophylaxis, reported lot# M019924 with expiration date of 02-SEP-2018, lot# N008823 with expiration date of 26-MAY-2018. No adverse effects were reported. It was stated that the vaccines underwent a temperature excursion of 32°F (degrees Fahrenheit) to 35°F for 40 minutes; No previous temperature excursion was done. The call was because of a "data logger". This is a non-valid case due to lack of patient identifier. Follow up information was received from the registered nurse 30-APR-2018. The nurse stated the temperature excursion was stable and they had two refrigerators that held the related vaccines. The nurse was not able to provide patients' names or initials, or ages, but was able to provide number of patients, gender information, and vaccination dates. This report referred to a male patient vaccinated with improperly stored VAQTA (lot# N019924 with expiration date 02-SEP-2018) on 26-SEP-2017. Upon receipt of follow-up information it was determined that this case is now valid because patient identifier was received. This is one of several reports received form the same reporter (link reports: 1710USA004069, 1805USA001661, 1805USA004617, 1805USA004618, 1805USA004590, 1805USA004591, 1805USA004592, 1805USA004593, 1805USA004674, 1805USA004675, 1805USA004676, 1805USA004677, 1805USA004678, 1805USA004679, 1805USA004680, 1805USA004681, 1805USA004682, 1805USA004683, 1805USA004967, 1805USA004968, 1805USA004969, 1805USA004970, 1805USA004971, 1805USA004972, 1805USA004974, 1805USA004975, 1805USA004976, 1805USA004977, 1805USA004978, 1805USA004979, 1805USA004980, 1805USA004981, 1805USA004982).
within 2 days of the vaccine. Patient fell a couple times and lost the ability to walk or use her hands. She was admitted on 3/6 for a 2 week course. She has yet to regain full function of her hands and feet. She was unable to move the other day so they referred her to a neurologist after and MRI.  She has had mild confusion at times. The neurologist wanted to do a DAT scan to look for possible Parkinson. She is having Parkinson disease type symptoms post vaccine. Today she is being transferred 911 to the hospital again because she is unable to get out of bed and use her arms or legs. Baseline before she was completely self sufficient living at home my herself.
pain; tightness; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (pain) and VACCINATION SITE REACTION (tightness) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced ARTHRALGIA (pain) and VACCINATION SITE REACTION (tightness). At the time of the report, ARTHRALGIA (pain) and VACCINATION SITE REACTION (tightness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information not provided. Treatment information not provided
Narrative: Patient experienced rash and itching after receiving the firs COVID-19 vaccination.
Information has been received from a pharmacist referring to a currently 71 year old female patient. The patient was allergic to codeine. She received an unspecified flu vaccine on an unspecified date 2 years ago (approximately in 2013) and "it  made her very sick". The reporter was unable to provide any additional information about how it made her sick. The patient did recover from the sick on unspecified dates. On an unknown date (reported as "a couple of months ago"), the patient was vaccinated with a dose of unspecified pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) (lot #, expiration date, dose and route not reported) and experienced an injection site reaction, which required unspecified treatment from her physician. The patient recovered from injection site reaction to an unspecified date. Additional information has been requested.
Chicken pox of more than 50 pox all over patient's body observed by a provider at clinic.
Injection site muscle pain - moderate:  onset within 10 minutes of injection and lasting 3 days Low-grade fever of 100.4:  onset next day and lasting one day
c/o tingling sensation on hands then face immediately after vacination, c/o nusea after but did not vomit, zofran 4 mg PO x1 given at 1:33 pm; pt verbalized feeling better and was discharged at 2:00 PM, drove self home.
Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; We had patients who were administered the vaccine that underwent temperature excursion; temperature excursioned product adminitered; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F), PRODUCT TEMPERATURE EXCURSION ISSUE (We had patients who were administered the vaccine that underwent temperature excursion) and PRODUCT ADMINISTRATION ERROR (temperature excursioned product adminitered) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C12A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Nov-2021 at 3:05 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 19-Nov-2021 at 3:05 PM, the patient experienced PRODUCT ADMINISTRATION ERROR (temperature excursioned product adminitered). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and PRODUCT TEMPERATURE EXCURSION ISSUE (We had patients who were administered the vaccine that underwent temperature excursion). At the time of the report, PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F), PRODUCT TEMPERATURE EXCURSION ISSUE (We had patients who were administered the vaccine that underwent temperature excursion) and PRODUCT ADMINISTRATION ERROR (temperature excursioned product adminitered) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications was provided by the reporter.  Patient received vaccine which was stored in an ultra cold freezer at minus 82 degrees Farenheight  No treatment medications was provided by the reporter.   This case was linked to MOD-2021-402935 (Patient Link).
New onset DVT/PE blood clots. Diagnosed after patient had new onset right calf pain and cramping about 9 days after receiving second Moderna COVID vaccine, came to hospital had an ultrasound which showed clot, then had CTA chest which confirmed pulmonary embolism (both done on 4/7/2021). She has no other known risk factors for thromboembolism, however a hypercoagulability work-up is also underway and will not be completed for several months.
No additional adverse effect reported; was administered a dose of improperly stored ROTATEQ; This spontaneous report was received from a physician referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, previous drug allergies or reactions, and concomitant medications were unknown not reported.       On 20-APR-2020, the patient was vaccinated with the first dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (strength, dose, lot #, and expiration date were not reported) and on 22-APR-2020, the patient received the second dose of an improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ)by oral route (lot # S005875 with an expiration date on 30-NOV-2020) for prophylaxis (strength and dose were not reported).  The dose of rotavirus vaccine, live, oral, pentavalent(ROTATEQ) was exposed to a temperature excursion of below 36 Fahrenheit (°F) (34.8°F) for 25 minutes. There was a previous temperature excursion below 36°F (34.5°F) for 1 hour and 24 minutes which was detected by the data logger.   No additional adverse effect reported.
Soreness at point of injection, migraine headache, chills, sweats, nausea, shortness of breath, tightness in chest. Extreme fatigue.
At 3 PM, approx. 20 hours after receiving the 2nd dose of Pfizer, I developed a slight fever of 99.4 and a slight headache.  I checked my vitals and found that my BP was high at 145/88 (normal BP is 110/60) and I had a rapid pulse/heart rate of 122-132 for the next 5 hours.  I also developed a red rash on my torso, but it wasn't itchy.   I was mostly concerned about the rapid pulse/heart rate.
A legal complaint was received from an attorney concerning a child who received series of Hib-Titer and Tri-Immunol from 4/2/98 through 5/6/99. The complaint states that as a result of exposure to Thimerosal in the vaccines, the child sustained neurological injuries and as a result of those injuries has been diagnosed with autism spectrum disorder. Exposure to thimerosal and autism spectrum disorder were considered medically important (OMIC).
101 fever for 2 days, shivering, muscular joint pain everywhere. Feels like the Flu
pt recv vax & exp swelling, pain & erythema @ the inj site;sx cleared up w/in a few days;
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 19-JUL-2016, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB lot # M000442, expiration date 31-MAR-2018 (dose and route of administration were not reported). There was no adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
Left arm pain, sore all the way up to neck, and down under my arms in my arm pit. Can't move my left arm at all or sleep on left side. Night sweats. Fever & chills. Body aches. No energy. Weak. And nausea.
Admin at 4:45pm, pt was taken to ER at 7pm. Reported of shortness of breath, dizziness, increase in heart rate.
No reaction when shots were given, but over the next day became swollen, red, and warm to touch. No fever reported.
Patient states he's having reaction to TD received 10/17, yesterday. He's feeling extreme fatigue, has fever of 100 and chills. Told pt to take MOTRIN 400mg PO every 6 hrs prn and follow-up needed if temp is elevated >100.5 for 24 hrs.
Racing heart rate; 104+fever; shortness of breath; Pain in Chest/Throat; Pain in Chest/Throat; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 15-years-old male patient received second dose of bnt162b2 (BNT162B2), Formulation: Solution for injection, Batch/Lot Number: EW0177; Expiration Date: Aug2021), via an intramuscular, administered in Arm Left on 04Jun2021 at 10:00 (at the age of 15-years-old) as DOSE 2, SINGLE for covid-19 immunisation. The patient was 15-years-old at the time of vaccination. Facility type vaccine was Other, Facility type vaccine other was a former grocery store now, vacant/(Facility name), No other vaccine in four weeks. No, other medications in two weeks, No, covid prior vaccination, No, vaccination administered facility was not military facility. The patient medical history included autism spectrum disorder, autism spectrum disorder. There were no concomitant medications. The patient previously took amoxicillin and experienced drug hypersensitivity. The patient previously received first dose of COMIRNATY (Lot Number: EJ6134), via an Intramuscular, administered in Arm Left on 14May2021 at 10:00 AM for COVID-19 immunisation. It was reported that on 04Jun2021 22:30, the patient experienced racing heart rate, 104+fever, shortness of breath, pain in chest/throat, pain in chest/throat. No, treatment for ae. Therapeutic measures were taken as a result of racing heart rate, 104+fever, shortness of breath. No, covid tested post vaccination. Yes, treatment (NSAID, call to on call physician, cool bath). The patient underwent lab tests and procedures which included body temperature was 104+ fever, heart rate was racing heart rate. The outcome of event was recovered.  Follow-up attempts are completed. No further information is expected.
C/o "frozen shoulder". Injection was given with a one inch needle ? injection given at top of deltoid muscle by RN administering.
Normal expected side effects: body aches, nausea, headache, chills.  Adverse reaction: fever (101-104F), Mac/pap rash, vomiting, extreme dizziness, palpitations.   OTC medications taken for symptoms: Tylenol, ibuprofen, Benadryl.  Prescription medication taken for symptoms:  Meclizine  Symptoms began about 18-20 hours after the vaccine dose #1 was received. It took about 32 hours for the adverse reaction symptoms to resolve.
Red, raised, feverish area around injection site, redness spread from injection site up to groin and around back of thigh.
Immediate post vaccine: injection site soreness (mild), still present at time of event reporting (42hrs post vaccine)   Approx 6hrs post vaccine: uncontrollable, full-body muscle tremors and chills. Came in waves lasting 15-45 seconds each, with rest periods of 30 seconds-2min. Overall, this event lasted approximately 1 hour.  9hrs post vaccine: patient was awoken around 3am with an increased resting heart rate of 100 bpm. Patient's normal resting heart rate is approx 76. Increased heart rate persisted until 18hrs post vaccine, at which point heart rate began to gradually return to normal. Normal resting heart rate returned about 26hrs post vaccine  9hrs post vaccine: acute joint discomfort, primarily in hips. Resolved around 17hrs post vaccine after patient took ibuprofen   Unknown start time: Fever of 101.4. Patient took temperature 16hrs post vaccine and took ibuprofen at this time. Body temp went down gradually, returning to normal approx 20hrs post vaccine  16hrs post vaccine: general fatigue. Unknown if reason is solely vaccine or combination of vaccine and lack of sleep due to adverse events. Continued until patient slept from 28-40hrs post vaccine.
she had sweating in the back; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (she had sweating in the back) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A, 012L20A and 051C2(Q)1A) for COVID-19 vaccination.     Concurrent medical conditions included Lupus erythematosus (Autoimmune disorder, with positive ANA, diagnosed with prior to receiving the vaccine a few years) and Joint pain. Concomitant products included PARACETAMOL (TYLENOL) for Joint pain.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (she had sweating in the back). At the time of the report, HYPERHIDROSIS (she had sweating in the back) outcome was unknown.            Treatment medication was not provided by the reporter.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   This case was linked to MOD-2021-294521 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Immediate onset pain in left arm, as well as weakness and decreased range of motion, particularly overhead. She took 4 weeks to report this because she thought she was "imagining" the symptoms. The symptoms lasted for about 6-8 weeks, then began to gradually improve on their own. Treatment consisted of stretching, OTC NSAIDs, and ice packs. She is currently doing well.
Pt had very large area on left arm with redness and warmth and was painful, happening 2 days after vaccination (started the night after vaccination) pt was put on antibiotic 4/14/16 in case of infection.
RASH APPROXIMATELY 30 HOURS AFTER IMMUNIZATIONS. HAD RASH ON SHOULDERS AND KNEES-NOW GONE.  ONLY HAS RASH ON GROIN/INGUINAL AREA.  SUBJECTIVE FEVER WITHIN 24 HOURS OF IMMUNIZATIONS.  SEEN IN ER 9/30/05 AND TOLD TO GIVE BENADRYL 1/2TSP PO Q 6 HOURS PRN.  F/U IN OFFICE 10/03/05. NO NEW ORDERS.
Right deltoid became swollen (3 in) reddened 24 hours after injection.  Patient did not report it until 05/16/2003.
Approximately 24 hours after vaccination I broke out into a rash on my hands and arms.  The rash/blisters are only located over the joints on my  fingers (bilateral hands), and bilateral elbows.  The blisters are very itchy and painful.  The finger joints have 1-2 per joint (back of the hand, NOT on the palm side), and cluster of 10-12 on each elbow. My MD stated since it started after vaccination to report to the VERS system, she will take blood work, and refer me to be seen by dermatology for possible biopsy.
Feels uncomfortable; Pain came back into shoulder joint; Tenderness in her tissue; Agonizing painful joint (rate it 20 for 10); Vaccine given on the given on the hardest part of the muscle and very high/liquid has gone to her joint rather than to the muscle/sensation felt like needle went into the joint and not the muscle/believes the shot was given incorrectly; A spontaneous report (United States) was received from a consumer who was also a 65-years-old, female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) on the hardest part of the muscle and very high; liquid has gone to her joint rather than to the muscle; sensation felt like needle went into the joint and not the muscle; believes the shot was given incorrectly/incorrect route of product administration and who experienced feels uncomfortable/malaise, agonizing painful joint (rate it 20 for 10); pain came back into shoulder joint/arthralgia and tenderness in her tissue/vaccination site pain.   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   On 17 Mar 2021, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number: 002B21A (via an unknown route) intramuscularly in the hardest part of the muscle for prophylaxis of COVID-19 infection.  On 17 Mar 2021, the patient received vaccine in the hardest part of the muscle and patient believes that the shot was given too high when administered. Patient stated that patient did not feel the needle go in, the sensation felt like the needle went into the joint and not the muscle. She added that it took 3.5 days for the severe pain to go away, but the day before reporting the pain woke patient from sleep. Patient described tenderness in tissue and the pain came back into shoulder joint was feeling uncomfortable. Patient believes the shot was given incorrectly.   Treatment for the event included advil for agonizing painful joint (rate it 20 for 10).  Action taken with mRNA-1273 in response to the events was not provided.  The events, Vaccine given on the given on the hardest part of the muscle and very high/liquid has gone to her joint rather than to the muscle/sensation felt like needle went into the joint and not the muscle/believes the shot was given incorrectly, was recovered on 17 Feb 2021 and the event agonizing painful joint (rate it 20 for 10) was recovered on 20 Feb 2021. The outcome of other reported events was not reported.; Sender's Comments:  MOD21-063203:MI Report
pt recv vax 4APR97 & mom reported pt crying non-stop x 4hr;mom describes cry as shrieky & different than nl cry;last dose of APAP 1115AM;mom instructed to give another dose @ this time;mom denies fever;seen by MD;
About 12 hours after the vaccine, I got a low grade fever and chills. These symptoms resolved within 18 hours. After that I just felt fatigue for a day and 1/2. On day 2, I started to get a stabbing pain in upper right quadrant of my body, under my breast right at the liver. That evening, the pain was severe, so I decided to go to the ER. They did blood tests and ultrasound and I was discharged to follow up with GI specialist to do a HIDA image scan to rule out gallstones. The HIDA scan came back normal. The blood work at the GI showed elevated liver enzymes. I was instructed to take vitamin E and to follow up within 8 weeks. At the follow up, my liver enzymes have normalized.
pt recvd vax; pt was tested for the antibody titer & showed no titer;